These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7223336)

  • 1. The role of coagulation-fibrinolytic system in diabetic vascular complications. Part 1: Urine factor excretion in diabetics and its role in the intraglomerular coagulation.
    Hoshiyama M
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):715-22. PubMed ID: 7223336
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of coagulation-fibrinolytic system in diabetic vascular complications. Part II: Involvement of coagulation-fibrinolytic system in diabetic vascular complications.
    Hoshiyama M
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):723-9. PubMed ID: 7223337
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemostatic function tests associated with diabetic microangiopathy.
    Fuller JH
    Horm Metab Res Suppl; 1981; 11():59-62. PubMed ID: 6947950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS; Krasik IaD
    Ter Arkh; 1974; 46(7):54-62. PubMed ID: 4408677
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma platelet factor 4 levels in diabetics with various vascular complications: measurement by radiommunoassay (author's transl)].
    Tsukada T; Tsutsui K; Ito T
    Rinsho Ketsueki; 1980 Mar; 21(3):302-7. PubMed ID: 7411869
    [No Abstract]   [Full Text] [Related]  

  • 8. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the nature orf blood coagulation factors in the human urine].
    Kuznik BI; Kalikhman IaL
    Vopr Med Khim; 1968; 14(5):503-5. PubMed ID: 5727583
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation in diabetic and non-diabetic claudicants.
    Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
    Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus, hemostatic function, and diabetic angiopathy].
    Zöller H; Gutmann W; Fährer E; Gross W
    Med Welt; 1976 Sep; 27(37):1742-3. PubMed ID: 979593
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J
    Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
    [No Abstract]   [Full Text] [Related]  

  • 13. Microalbuminuria, as predictor of late diabetic complications. A prospective study.
    Fekete T; Bogdan E; Crăciunescu C
    Med Interne; 1990; 28(2):131-4. PubMed ID: 2270422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and excretion of factors of coagulation and fibrinolysis with urine in patients with pyelonephritis].
    Zorina SS
    Klin Med (Mosk); 1975 Mar; 53(3):48-52. PubMed ID: 1117683
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic microangiopathy and urinary glycosaminoglycans.
    Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
    Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The coagulation picture and plasma clearance capacity in atherosclerotic diabetics].
    Miti L; Sprovieri G; Breschi L; Civerchia D; Foglia A
    Arch Sci Med (Torino); 1978; 135(2):187-96. PubMed ID: 356822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular endothelial growth factor in the progression of diabetic vascular complications.
    Mahdy RA; Nada WM; Hadhoud KM; El-Tarhony SA
    Eye (Lond); 2010 Oct; 24(10):1576-84. PubMed ID: 20508651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.